Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $58.3500 (2.97%) ($58.3500 - $58.3500) on Wed. Dec. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.23% (three month average) | RSI | 54 | Latest Price | $58.3500(2.97%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(34%) IWO(33%) IWM(31%) SDY(30%) | Factors Impacting HALO price | HALO will decline at least -1.115% in a week (0% probabilities). XBI(-11%) VIXM(-11%) IGOV(-8%) TLT(-7%) GLD(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.115% (StdDev 2.23%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $56.97(2.42%) | 10 Day Moving Average | $57.48(1.51%) | 20 Day Moving Average | $57.09(2.21%) | To recent high | -1.7% | To recent low | 51.2% | Market Cap | $7.975b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |